Azenta, Inc. (NASDAQ:AZTA) Position Lowered by Avior Wealth Management LLC

Avior Wealth Management LLC decreased its stake in shares of Azenta, Inc. (NASDAQ:AZTA) by 7.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 15,800 shares of the company’s stock after selling 1,265 shares during the period. Avior Wealth Management LLC’s holdings in Azenta were worth $790,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of AZTA. American Century Companies Inc. increased its stake in shares of Azenta by 66.3% in the second quarter. American Century Companies Inc. now owns 69,955 shares of the company’s stock valued at $3,681,000 after purchasing an additional 27,882 shares during the period. Vanguard Personalized Indexing Management LLC boosted its stake in shares of Azenta by 19.6% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 7,422 shares of the company’s stock valued at $375,000 after buying an additional 1,215 shares during the period. Hsbc Holdings PLC acquired a new stake in shares of Azenta during the 2nd quarter valued at $232,000. Intech Investment Management LLC acquired a new stake in shares of Azenta during the 2nd quarter valued at $609,000. Finally, Benjamin F. Edwards & Company Inc. lifted its stake in shares of Azenta by 150.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 1,588 shares of the company’s stock valued at $84,000 after purchasing an additional 955 shares during the last quarter. Institutional investors own 99.08% of the company’s stock.

Azenta Trading Down 1.1 %

Azenta stock opened at $54.16 on Friday. The company has a market cap of $2.47 billion, a P/E ratio of -18.24 and a beta of 1.47. Azenta, Inc. has a 1-year low of $38.82 and a 1-year high of $67.86. The company has a fifty day simple moving average of $48.89 and a 200 day simple moving average of $49.10.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings data on Tuesday, November 12th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.10 by $0.08. The company had revenue of $170.00 million during the quarter, compared to the consensus estimate of $169.66 million. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. The company’s quarterly revenue was down 1.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.13 EPS. On average, equities research analysts forecast that Azenta, Inc. will post 0.41 EPS for the current year.

Insiders Place Their Bets

In related news, CFO Herman Cueto sold 712 shares of Azenta stock in a transaction that occurred on Tuesday, November 19th. The shares were sold at an average price of $40.07, for a total transaction of $28,529.84. Following the sale, the chief financial officer now directly owns 23,892 shares of the company’s stock, valued at approximately $957,352.44. The trade was a 2.89 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO John Marotta purchased 12,717 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The shares were bought at an average cost of $39.48 per share, for a total transaction of $502,067.16. Following the completion of the acquisition, the chief executive officer now directly owns 99,612 shares in the company, valued at $3,932,681.76. The trade was a 14.63 % increase in their position. The disclosure for this purchase can be found here. Insiders sold 1,423 shares of company stock worth $57,020 in the last quarter. 10.62% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts recently issued reports on AZTA shares. Evercore ISI reduced their price objective on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a research note on Tuesday, October 1st. Stephens restated an “overweight” rating and set a $60.00 price objective on shares of Azenta in a report on Thursday, January 2nd. Finally, Needham & Company LLC decreased their target price on shares of Azenta from $69.00 to $55.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, Azenta presently has a consensus rating of “Moderate Buy” and an average target price of $61.60.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.